HTR2A and alcoholic fatty liver disease: SAveRUNNER predicted that cyproheptadine, which targets both HRH1 and the serotonin 2A receptor, HTR2A, instead of HRH1 alone would be the best antihistamine for treating non-alcoholic fatty liver disease (Figure 6B).